ASX announcements

Date	Title
29/12/2016	Regeneus and AGC Asahi Glass to collaborate on Progenza regenerative medicine therapy in Japan
28/12/2016	Trading halt request
19/10/2016	Results of Annual General Meeting
19/10/2016	CEO Presentation to 2016 Annual General Meeting
19/10/2016	Chairman's Address to Shareholders
17/10/2016	Japan Update
14/09/2016	Notice of Annual General Meeting and Explanatory Statement
12/09/2016	Regeneus receives R&D tax incentive refund of $2.7m
24/08/2016	2016 Full-year results presentation
24/08/2016	Regeneus reports 2016 full-year results
09/08/2016	Date of Annual General Meeting 2016
05/08/2016	ASX Price Query Response - August 2016
01/08/2016	European patent to grant on stem cell secretions technology for acne
17/05/2016	Australian Research Council Linkage Grant to progress research into treating chronic pain with next generation stem cells
16/05/2016	Enrolment completed and positive safety review in Progenza stem cell trial for osteoarthritis
09/03/2016	ASX Price Query Response
29/02/2016	Regeneus reports half-year results
12/01/2016	Positive safety of first cohort in Progenza stem cell trial for knee osteoarthritis